HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sen. Grassley’s Proposed Drug Safety Office Would Have Labeling Authority

This article was originally published in The Tan Sheet

Executive Summary

Sen. Charles Grassley (R-Iowa) will propose legislation creating an independent drug safety office at FDA that would have authority to alter drug labeling and possibly suspend direct-to-consumer advertising

You may also be interested in...

Health Chair Enzi Envisions Timely Crawford Confirmation

Senate Health Committee Chairman Michael Enzi (R-Wyo.) expects a vote on Acting FDA Commissioner Lester Crawford's nomination to the permanent post to proceed as scheduled on April 13

Crawford Must Answer “Tough Questions” During Confirmation – Grassley

Sen. Charles Grassley (R-Iowa) is noncommittal on the nomination of FDA Acting Commissioner Lester Crawford to fill the post on a permanent basis

Senate Hearings Probe FDA Authority On Drug Label Changes, Safety Trials

Giving FDA the authority to require changes to drug labeling could help the agency get drug safety information to the public more quickly, FDA Office of New Drugs Deputy Director Sandra Kweder told the Senate Health Committee March 1

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts